Risk assessment of genotoxic mutagens with thresholds: A brief introduction

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 678, Issue 2, 2009, Pages 72-75

  Kirsch Volders, M ^a   Gonzalez, L ^a   Carmichael, P ^b   Kirkland, D ^c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNILEVER RESEARCH   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

Carcinogen; Genotoxin; Mutagen; NOAEL; NOEL; Risk assessment; Threshold

Indexed keywords

DNA; MUTAGENIC AGENT;

ARTICLE; ASSAY; CALCULATION; CELL CYCLE; CHROMATIN; DNA ADDUCT; DNA DAMAGE; DOSE RESPONSE; EXON; GENE MUTATION; GENETICS; GENOTOXICITY; MEIOSIS; MUTAGENIC ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE;

DNA DAMAGE; HUMANS; MODELS, STATISTICAL; MUTAGENICITY TESTS; MUTAGENS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; THRESHOLD LIMIT VALUES;

EID: 69449095701     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.05.001     Document Type: Article

References (22)

1. Parry J.M. Reflections on the implications of thresholds of mutagenic activity for the labelling of chemicals by the European Union. Mutat. Res. 464 (2000) 155-158
2. Bolt H.M. Genotoxicity-threshold or not? Introduction of cases of industrial chemicals. Toxicol. Lett. 140-141 (2003) 43-51
3. Bolt H.M., and Degen G.H. How to assess human carcinogenic risk of chemicals? Contributions of the EUROTOX specialty section carcinogenesis. Toxicol. Sci. 81 (2004) 3-6
4. Nakae D., Wanibuchi H., Konishi Y., and Fukushima S. Possible involvement of adaptation mechanisms in the achievement of an ineffective dose range for the carcinogenicity of genotoxic carcinogens. Genes Environ. 30 (2008) 125-131
5. Cohen S.M. Thresholds in genotoxicty and carcinogenicity: urinary bladder carcinogenesis. Genes Environ. 30 (2008) 132-138
6. Kitchin K.T. Theoretical and experimental approaches to address possible thresholds of response in carcinogenicity. Genes Environ. 30 (2008) 150-159
7. Nagao M., Ishikawa S., Nakagama H., and Watanabe M. Extrapolation of the animal carcinogenesis threshold to humans. Genes Environ. 30 (2008) 160-165
8. In: Parry J.M., and Sarrif A. (Eds). Dose-response and threshold-mediated mechanisms in mutagenesis. Special Issue of Mutation Research. Mutat. Res. 464 (2000) 1-158
9. Elhajouji A., Hummelen V.P., and Kirsch-Volders M. Indications for a threshold of chemically induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen 26 (1995) 292-304
10. Elhajouji A., Tibaldi F., and Kirsch-Volders M. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12 (1997) 133-140
11. Kirsch-Volders M., Aardema M., and Elhajouji A. Concepts of threshold in mutagenesis and carcinogenesis. Mutat. Res. 464 (2000) 3-11
12. Speit G., Autrup H., Crebelli R., Henderson L., Kirsch-Volders M., Madle S., Parry J.M., Sarrif A.M., and Vrijhof H. Thresholds in genetic toxicology-concluding remarks. Mutat. Res. 464 (2000) 149-153
13. Lynch A., Harvey J., Aylott M., Nicholas E., Burman M., Siddiqui A., Walker S., and Rees R. Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis 18 (2003) 345-353
14. Lutz W.K. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. Mutat. Res. 405 (1998) 117-124
15. Lovell D.P. Experimental design and statistical analysis of studies to demonstrate a threshold in genetic toxicology: a mini-review. Genes Environ. 30 (2008) 139-149
16. G.E. Johnson, S.H. Doak,, S.M. Griffiths, E.L. Quick, D.O.F. Skibinski, Z.M. Zaïr, G.J. Jenkins, Non-linear dose-response of DNA-reactive genotoxins: recommendations for analysis, Mutat. Res. (2009) this issue.
17. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., and Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 140-141 (2003) 63-74
18. Cammerer Z., Elhajouji A., Kirsch-Volders M., and Suter W. Comparison of the peripheral blood micronucleus test using flow cytometry in rat and mouse exposed to aneugens after single-dose applications. Mutagenesis 22 (2008) 129-134
19. Jenkins G.J., Doak S.H., Johnson G.E., Quick E., Waters E.M., and Parry J.M. Do dose response thresholds exist for genotoxic alkylating agents?. Mutagenesis 20 (2005) 389-398
20. Kirkland D.J., Aardema M., Banduhn N., Carmichael P., Fautz R., Meunier J.R., and Pfuhler S. In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results. Mutagenesis 22 (2007) 161-175
21. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., and Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 67 (2007) 3904-3911
22. Zeiger E., Recio L., Fennell T.R., Haseman J.K., Snyder R.W., and Friedman M. Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol. Sci. 10 (2009) 247-257